Anti CD19 Gene Therapy for B-cell Lymphoma

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 20, 2025

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions

B-cell Lymphoma

Interventions

DRUG

Anti-CD19 gene injection

Intravenous infusion of Anti-CD19 gene injection （three dosage groups）

Trial Locations (1)

RECRUITING

Anhui Provincial Hospital, Hefei

All Listed Sponsors

lead

Anhui Provincial Hospital

OTHER_GOV